Richard Scott Struthers, President & CEO: Crinetics Pharmaceuticals CRNX Sell · Filed 25/03/21

Trade details

Type: Insider sale
Amount: $562,540.71
Shares · price: 16,463 sh · $34.17 a share
Held after: 330,022 sh
Stock: Crinetics Pharmaceuticals CRNX
Person: Richard Scott StruthersPresident & CEO
Trade date: 25/03/19
Filed: 25/03/21
Days to filing: 2 days

Sold 4.8% of holdings

Share of holding sold: 4.8%

Crinetics Pharmaceuticals trades, last 26 weeks

What else happened in Crinetics Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/02/17~25/04/18

Richard Scott Struthers's recent trades

Richard Scott StruthersPresident & CEO
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$489.7K
13,196 sh
$489.7K
Filed 03/18
Traded 03/16
Richard Scott StruthersPresident & CEO
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$331.8K
8,785 sh
$331.8K
Filed 03/18
Traded 03/16
Richard Scott StruthersPresident & CEO
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$180K
4,000 sh
$180K
Filed 25/09/30
Traded 25/09/26
Richard Scott StruthersPresident & CEO
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$30.5K
875 sh
$30.5K
Filed 25/03/21
Traded 25/03/19
Richard Scott StruthersPresident & CEO
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$575.7K
10,000 sh
$575.7K
Filed 24/12/04
Traded 24/12/02

Richard Scott Struthers, CEO — sold $562.5K of Crinetics Pharmaceuticals CRNX · 4.8% of holdings · 10b5-1 plan | Whalegun